Swedish Orphan Biovitrum AB (publ)
STO:SOBI

Watchlist Manager

Swedish Orphan Biovitrum AB (publ)

STO:SOBI

Watchlist

Earnings Calls

Price: 270 SEK -0.81% Market Closed

Updated: Jun 15, 2024

Have any thoughts about
Swedish Orphan Biovitrum AB (publ)?

Write Note

Write Note Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Walt Disney Co NYSE:DIS	Media

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

This note will be permanently deleted.

Delete

Cancel

Ask me anything about

Swedish Orphan Biovitrum AB (publ)

What unique competitive advantages
does Swedish Orphan Biovitrum AB (publ) hold over its rivals?

What risks and challenges
does Swedish Orphan Biovitrum AB (publ) face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Swedish Orphan Biovitrum AB (publ).

What unique competitive advantages
does Swedish Orphan Biovitrum AB (publ) hold over its rivals?

What risks and challenges
does Swedish Orphan Biovitrum AB (publ) face in the near future?

Summarize the latest earnings call
of Swedish Orphan Biovitrum AB (publ).

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Swedish Orphan Biovitrum AB (publ).

Provide P/S
for Swedish Orphan Biovitrum AB (publ).

Provide P/E
for Swedish Orphan Biovitrum AB (publ).

Provide P/OCF
for Swedish Orphan Biovitrum AB (publ).

Provide P/FCFE
for Swedish Orphan Biovitrum AB (publ).

Provide P/B
for Swedish Orphan Biovitrum AB (publ).

Provide EV/S
for Swedish Orphan Biovitrum AB (publ).

Provide EV/GP
for Swedish Orphan Biovitrum AB (publ).

Provide EV/EBITDA
for Swedish Orphan Biovitrum AB (publ).

Provide EV/EBIT
for Swedish Orphan Biovitrum AB (publ).

Provide EV/OCF
for Swedish Orphan Biovitrum AB (publ).

Provide EV/FCFF
for Swedish Orphan Biovitrum AB (publ).

Provide EV/IC
for Swedish Orphan Biovitrum AB (publ).

Show me price targets
for Swedish Orphan Biovitrum AB (publ) made by professional analysts.

What are the Revenue projections
for Swedish Orphan Biovitrum AB (publ)?

How accurate were the past Revenue estimates
for Swedish Orphan Biovitrum AB (publ)?

What are the Net Income projections
for Swedish Orphan Biovitrum AB (publ)?

How accurate were the past Net Income estimates
for Swedish Orphan Biovitrum AB (publ)?

What are the EPS projections
for Swedish Orphan Biovitrum AB (publ)?

How accurate were the past EPS estimates
for Swedish Orphan Biovitrum AB (publ)?

What are the EBIT projections
for Swedish Orphan Biovitrum AB (publ)?

How accurate were the past EBIT estimates
for Swedish Orphan Biovitrum AB (publ)?

Compare the revenue forecasts
for Swedish Orphan Biovitrum AB (publ) with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Swedish Orphan Biovitrum AB (publ) and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Swedish Orphan Biovitrum AB (publ) against its competitors.

Analyze the profit margins
(gross, operating, and net) of Swedish Orphan Biovitrum AB (publ) compared to its peers.

Compare the P/E ratios
of Swedish Orphan Biovitrum AB (publ) against its peers.

Discuss the investment returns and shareholder value creation
comparing Swedish Orphan Biovitrum AB (publ) with its peers.

Analyze the financial leverage
of Swedish Orphan Biovitrum AB (publ) compared to its main competitors.

Show all profitability ratios
for Swedish Orphan Biovitrum AB (publ).

Provide ROE
for Swedish Orphan Biovitrum AB (publ).

Provide ROA
for Swedish Orphan Biovitrum AB (publ).

Provide ROIC
for Swedish Orphan Biovitrum AB (publ).

Provide ROCE
for Swedish Orphan Biovitrum AB (publ).

Provide Gross Margin
for Swedish Orphan Biovitrum AB (publ).

Provide Operating Margin
for Swedish Orphan Biovitrum AB (publ).

Provide Net Margin
for Swedish Orphan Biovitrum AB (publ).

Provide FCF Margin
for Swedish Orphan Biovitrum AB (publ).

Show all solvency ratios
for Swedish Orphan Biovitrum AB (publ).

Provide D/E Ratio
for Swedish Orphan Biovitrum AB (publ).

Provide D/A Ratio
for Swedish Orphan Biovitrum AB (publ).

Provide Interest Coverage Ratio
for Swedish Orphan Biovitrum AB (publ).

Provide Altman Z-Score Ratio
for Swedish Orphan Biovitrum AB (publ).

Provide Quick Ratio
for Swedish Orphan Biovitrum AB (publ).

Provide Current Ratio
for Swedish Orphan Biovitrum AB (publ).

Provide Cash Ratio
for Swedish Orphan Biovitrum AB (publ).

What is the historical Revenue growth
over the last 5 years for Swedish Orphan Biovitrum AB (publ)?

What is the historical Net Income growth
over the last 5 years for Swedish Orphan Biovitrum AB (publ)?

What is the current Free Cash Flow
of Swedish Orphan Biovitrum AB (publ)?

Discuss the annual earnings per share (EPS)
trend over the past five years for Swedish Orphan Biovitrum AB (publ).

SOBI

Balance Sheet

Cash & Cash Equivalents

Swedish Orphan Biovitrum AB (publ)
Cash & Cash Equivalents

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Swedish Orphan Biovitrum AB (publ)
Cash & Cash Equivalents Peer Comparison

Comparables:

BIOG B

HNSA

BONEX

VITR

BIOA B

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

	Cash & Cash Equivalents	CAGR 3Y	CAGR 5Y	CAGR 10Y
Swedish Orphan Biovitrum AB (publ) STO:SOBI	Cash & Cash Equivalents kr527m	CAGR 3-Years -6%	CAGR 5-Years 3%	CAGR 10-Years -1%
Biogaia AB STO:BIOG B	Cash & Cash Equivalents kr1.5B	CAGR 3-Years 2%	CAGR 5-Years 40%	CAGR 10-Years N/A
Hansa Biopharma AB STO:HNSA	Cash & Cash Equivalents kr541.5m	CAGR 3-Years -19%	CAGR 5-Years 10%	CAGR 10-Years N/A
Bonesupport Holding AB STO:BONEX	Cash & Cash Equivalents kr187.2m	CAGR 3-Years -18%	CAGR 5-Years -3%	CAGR 10-Years N/A
Vitrolife AB STO:VITR	Cash & Cash Equivalents kr947m	CAGR 3-Years -5%	CAGR 5-Years 13%	CAGR 10-Years 31%
BioArctic AB STO:BIOA B	Cash & Cash Equivalents kr611.6m	CAGR 3-Years -15%	CAGR 5-Years -8%	CAGR 10-Years N/A

What is Swedish Orphan Biovitrum AB (publ)'s Cash & Cash Equivalents?

Cash & Cash Equivalents
527m SEK

Based on the financial report for Mar 31, 2024, Swedish Orphan Biovitrum AB (publ)'s Cash & Cash Equivalents amounts to 527m SEK.

What is Swedish Orphan Biovitrum AB (publ)'s Cash & Cash Equivalents growth rate?

Cash & Cash Equivalents CAGR 10Y
-1%

Over the last year, the Cash & Cash Equivalents growth was 166%. The average annual Cash & Cash Equivalents growth rates for Swedish Orphan Biovitrum AB (publ) have been -6% over the past three years , 3% over the past five years , and -1% over the past ten years .

Swedish Orphan Biovitrum AB (publ)
STO:SOBI

Swedish Orphan Biovitrum AB (publ)
Cash & Cash Equivalents

Swedish Orphan Biovitrum AB (publ)
Cash & Cash Equivalents Peer Comparison

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

See Also

What is Swedish Orphan Biovitrum AB (publ)'s Cash & Cash Equivalents?

Cash & Cash Equivalents
527m SEK

What is Swedish Orphan Biovitrum AB (publ)'s Cash & Cash Equivalents growth rate?

Cash & Cash Equivalents CAGR 10Y
-1%

Company

Help

Tools

Stocks

Swedish Orphan Biovitrum AB (publ) STO:SOBI

Swedish Orphan Biovitrum AB (publ) Cash & Cash Equivalents

Swedish Orphan Biovitrum AB (publ) Cash & Cash Equivalents Peer Comparison

Competitive Cash & Cash Equivalents Analysis Latest Figures & CAGR of Competitors

See Also

What is Swedish Orphan Biovitrum AB (publ)'s Cash & Cash Equivalents? Cash & Cash Equivalents 527m SEK

What is Swedish Orphan Biovitrum AB (publ)'s Cash & Cash Equivalents growth rate? Cash & Cash Equivalents CAGR 10Y -1%

Company

Help

Tools

Stocks

Swedish Orphan Biovitrum AB (publ)
STO:SOBI

Swedish Orphan Biovitrum AB (publ)
Cash & Cash Equivalents

Swedish Orphan Biovitrum AB (publ)
Cash & Cash Equivalents Peer Comparison

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

What is Swedish Orphan Biovitrum AB (publ)'s Cash & Cash Equivalents?

Cash & Cash Equivalents
527m SEK

What is Swedish Orphan Biovitrum AB (publ)'s Cash & Cash Equivalents growth rate?

Cash & Cash Equivalents CAGR 10Y
-1%